References
- Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: 2021 report [internet], Global Initiative for Chronic Obstructive Lung Disease; 2021 [cited 2021 Aug 8]. Available from: https://goldcopd.org/
- Buist AS, McBurnie MA, Vollmer WM, et al. BOLD Collaborative Research Group. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet. 2007;1;370(9589):741–50. 10.1016/S0140-6736(07)61377-4 [PubMed] [CrossRef] [Google Scholar]
- Chronic obstructive pulmonary disease (COPD) in Vietnam [internet]. Geneva: World Health Organization; 2021. [cited 2021 Oct 20]. Available from: https://www.who.int/vietnam/health-topics/chronic-obstructive-pulmonary-disease-copd
- Chronic obstructive pulmonary disease (COPD). Geneva: World Health Organization; 2021. [cited 2021 Oct 20]. Available from: https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd).
- Beaglehole R, Bonita R, Horton R, et al. Priority actions for the noncommunicable disease crisis. Lancet. 2011;377:1438–1447
- Meghji J, Mortimer K, Agusti A, et al. Improving lung health in low-income and middle-income countries: from challenges to solutions. Lancet. 2021;397:928–940.
- Asher MI, Rutter CE, Bissell K, et al. Worldwide trends in the burden of asthma symptoms in school-aged children: Global Asthma Network Phase I cross-sectional study. Lancet. 2021;398:1569–1580.
- Halpin DMG, Celli BR, Criner GJ, et al. The GOLD Summit on chronic obstructive pulmonary disease in low- and middle-income countries. Int J Tuberc Lung Dis. 2019;23:1131–1141.
- WHO . World Health Organization; Geneva: 2013. [cited 2023 Oct 24] Global Action Plan for the prevention and control of noncommunicable diseases 2013–2020.
- Global Initiative for Chronic Obstructive Lung Disease. 2023. [cited 2023 Oct 24] Available from: https://goldcopd.org/2023-gold-report-2/
- Alsuwaigh R, Yii A, Loh CH, Xu X, Bahety P, Navarro Rojas AA, Milea D, Tee A. A comparison of GOLD 2019 and 2023 recommendations to contemporaneous real-world inhaler treatment patterns for chronic obstructive pulmonary disease management in Singapore. J Thorac Dis. 2024;16(2):847-861. doi: 10.21037/jtd-22-1769. Epub 2024 Feb 21. PMID: 38505044; PMCID: PMC10944796.
- Celli B, Fabbri L, Criner G, et al. Definition and nomenclature of chronic obstructive pulmonary disease: time for its revision. Am J Respir Crit Care Med. 2022;206:1317–1325.
- Global Initiative for Chronic Obstructive Lung Disease. 2022. [cited 2023 Oct 24]Available from: www.goldcopd.org
- Agustí A, Melén E, DeMeo DL, Breyer-Kohansal R, Faner R. Pathogenesis of chronic obstructive pulmonary disease: understanding the contributions of gene-environment interactions across the lifespan. Lancet Respir Med. 2022;10:512–524.
- Vollmer WM, Gíslason T, Burney P, et al. Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study. Eur Respir J. 2009; 343:588-597.
- Agusti A, Vogelmeier CF. GOLD 2024: a brief overview of key changes. J Bras Pneumol. 2023;49(6):e20230369. doi: 10.36416/1806-3756/ e20230369. PMID: 38126685; PMCID: PMC10760434
- Cazzola M. Outcomes for COPD pharmacological trials: from lung function to biomarkers. European Respiratory Journal. 2008;31.2: 416-469.
- Mahler DA, Donohue JF, Barbee RA, et al. Efficacy of salmeterol xinafoate in the treatment of COPD. Chest. 1999;1154:957-965.
- Schermer T, Heijdra Y, Zadel S, et al. Flow and volume responses after routine salbutamol reversibility testing in mild to very severe COPD. Respir Med. 2007;101(6):1355-62.
- Calverley PM, Albert P, Walker PP. Bronchodilator reversibility in chronic obstructive pulmonary disease: use and limitations. The Lancet Respiratory Medicine 2013;1(7): 564-573.
- Svensson L, Ankerst J, Bjermer L, Tufvesson E. Airway resistance and reactance in COPD patients and healthy smokers and effect of bronchodilators. European Respiratory Journal. 2011;38(55) : 4053.
- Kanda S, Fujimoto K, Komatsu Y, Yasuo M, Hanaoka M, Kubo K. Evaluation of respiratory impedance in asthma and COPD by an impulse oscillation system. Intern Med. 2010;49(1):23-30.